2023 Q1 Form 10-K Financial Statement
#000166357723000137 Filed on March 30, 2023
Income Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
Revenue | $5.000K | $5.000K | $279.3K |
YoY Change | -91.66% | -98.02% | -57.9% |
Cost Of Revenue | $0.00 | $4.808K | |
YoY Change | 45.7% | ||
Gross Profit | $5.000K | $5.000K | $274.5K |
YoY Change | -91.45% | -98.02% | -58.42% |
Gross Profit Margin | 100.0% | 100.0% | 98.28% |
Selling, General & Admin | $128.3K | $118.0K | $494.2K |
YoY Change | -3.87% | 17.25% | 8.82% |
% of Gross Profit | 2565.2% | 2359.6% | 180.04% |
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $4.640K | $4.740K | $18.74K |
YoY Change | 1.09% | 0.85% | 4.46% |
% of Gross Profit | 92.8% | 94.8% | 6.83% |
Operating Expenses | $132.9K | $122.7K | $512.9K |
YoY Change | -3.7% | 16.53% | 8.66% |
Operating Profit | -$127.9K | -$117.7K | -$238.4K |
YoY Change | 60.8% | -179.78% | -226.77% |
Interest Expense | $1.384M | -$282.9K | $1.163M |
YoY Change | -611.04% | -11.55% | -184.85% |
% of Operating Profit | |||
Other Income/Expense, Net | $1.387M | $986.5K | |
YoY Change | 927.67% | -21.76% | |
Pretax Income | -$1.515M | -$400.6K | -$1.225M |
YoY Change | 606.26% | 142.22% | 14.18% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$1.515M | -$400.6K | -$1.225M |
YoY Change | 606.26% | 142.22% | 14.18% |
Net Earnings / Revenue | -30301.12% | -8011.6% | -438.56% |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$0.33 | -$0.09 | -$0.27 |
COMMON SHARES | |||
Basic Shares Outstanding | 4.594M shares | 4.540M shares | 4.540M shares |
Diluted Shares Outstanding | 4.540M shares | 4.540M shares |
Balance Sheet
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $29.14K | $81.38K | $81.38K |
YoY Change | 16.1% | 23.23% | 23.23% |
Cash & Equivalents | $29.14K | $81.38K | |
Short-Term Investments | |||
Other Short-Term Assets | $3.810K | $9.500K | $9.500K |
YoY Change | -23.8% | 16.85% | 16.85% |
Inventory | |||
Prepaid Expenses | |||
Receivables | $40.18K | $19.07K | $19.07K |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $73.13K | $109.9K | $110.0K |
YoY Change | 108.17% | 48.09% | 48.1% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $132.7K | $136.8K | $136.8K |
YoY Change | -10.6% | -10.59% | -10.6% |
TOTAL ASSETS | |||
Total Short-Term Assets | $73.13K | $109.9K | $110.0K |
Total Long-Term Assets | $132.7K | $136.8K | $136.8K |
Total Assets | $205.9K | $246.8K | $246.8K |
YoY Change | 12.13% | 8.58% | 8.57% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $126.1K | $1.202M | $1.202M |
YoY Change | -86.66% | ||
Accrued Expenses | $2.110M | $1.956M | $1.956M |
YoY Change | 32.32% | 32.59% | 32.59% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $433.6K | $433.6K | $433.6K |
YoY Change | -5.92% | -5.92% | -5.92% |
Long-Term Debt Due | $40.00K | $40.00K | $40.00K |
YoY Change | 0.0% | 0.0% | 0.0% |
Total Short-Term Liabilities | $2.726M | $3.645M | $3.645M |
YoY Change | -11.11% | 19.07% | 19.07% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $5.635M | $3.242M | $3.242M |
YoY Change | 105.16% | 25.59% | 25.59% |
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $5.635M | $3.242M | $3.242M |
YoY Change | 105.16% | 25.59% | 25.59% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $2.726M | $3.645M | $3.645M |
Total Long-Term Liabilities | $5.635M | $3.242M | $3.242M |
Total Liabilities | $8.362M | $6.887M | $6.887M |
YoY Change | 43.82% | 22.05% | 22.05% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$38.51M | -$37.00M | |
YoY Change | 3.42% | ||
Common Stock | $4.540K | $4.540K | |
YoY Change | 0.0% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$8.156M | -$6.641M | -$6.641M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $205.9K | $246.8K | $246.8K |
YoY Change | 12.13% | 8.58% | 8.57% |
Cashflow Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$1.515M | -$400.6K | -$1.225M |
YoY Change | 606.26% | 142.22% | 14.18% |
Depreciation, Depletion And Amortization | $4.640K | $4.740K | $18.74K |
YoY Change | 1.09% | 0.85% | 4.46% |
Cash From Operating Activities | -$51.72K | -$45.51K | $45.17K |
YoY Change | 26.32% | -129.59% | -87.94% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $530.00 | $520.00 | $2.530K |
YoY Change | -112.13% | ||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | -$525.00 | -$520.00 | -$2.530K |
YoY Change | -87.87% | ||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 0.000 | -$27.30K | |
YoY Change | -100.0% | -91.56% | |
NET CHANGE | |||
Cash From Operating Activities | -$51.72K | -45.51K | $45.17K |
Cash From Investing Activities | -$525.00 | -520.0 | -$2.530K |
Cash From Financing Activities | 0.000 | -$27.30K | |
Net Change In Cash | -$52.24K | -46.03K | $15.34K |
YoY Change | -373.66% | -49.12% | |
FREE CASH FLOW | |||
Cash From Operating Activities | -$51.72K | -$45.51K | $45.17K |
Capital Expenditures | $530.00 | $520.00 | $2.530K |
Free Cash Flow | -$52.25K | -$46.03K | $42.64K |
YoY Change | 27.61% | -129.92% | -89.22% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001085277 | |
CY2022 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2022 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2022 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
CY2022 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2022Q4 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
usd | |
CY2022 | us-gaap |
Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
|
usd | |
CY2022 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
usd | |
CY2022 | us-gaap |
Payments For Loans
PaymentsForLoans
|
usd | |
CY2022 | us-gaap |
Interest Paid
InterestPaid
|
usd | |
CY2022 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
usd | |
CY2021 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
usd | |
CY2022 | us-gaap |
Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
|
usd | |
CY2021 | us-gaap |
Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
|
usd | |
CY2022 | us-gaap |
Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
|
usd | |
CY2021 | us-gaap |
Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
|
usd | |
CY2022 | SKVI |
Common Stock Payable Conversion Of Debt Value
CommonStockPayableConversionOfDebtValue
|
usd | |
CY2022Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
usd | |
CY2021Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
usd | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
shares | |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
||
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
shares | |
CY2022 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
shares | |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
||
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
shares | |
CY2022 | dei |
Document Type
DocumentType
|
10-K | |
CY2022 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2022 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-12-31 | |
CY2022 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2022 | dei |
Entity File Number
EntityFileNumber
|
000-25911 | |
CY2022 | dei |
Entity Registrant Name
EntityRegistrantName
|
Skinvisible, Inc. | |
CY2022 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | |
CY2022 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
88-0344219 | |
CY2022 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
6320 South Sandhill Road | |
CY2022 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 10 | |
CY2022 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Las Vegas | |
CY2022 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NV | |
CY2022 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
89120 | |
CY2022 | dei |
City Area Code
CityAreaCode
|
702 | |
CY2022 | dei |
Local Phone Number
LocalPhoneNumber
|
433.7154 | |
CY2022 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2022 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2022 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2022 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2022 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2022 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2022 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2022Q2 | dei |
Entity Public Float
EntityPublicFloat
|
551261 | usd |
CY2023Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
4593843 | shares |
CY2022 | dei |
Auditor Name
AuditorName
|
Gries & Associates, LLC | |
CY2022 | dei |
Auditor Location
AuditorLocation
|
Denver, Colorado | |
CY2022 | dei |
Auditor Firm
AuditorFirmId
|
6778 | |
CY2022Q4 | us-gaap |
Cash
Cash
|
81378 | usd |
CY2021Q4 | us-gaap |
Cash
Cash
|
66037 | usd |
CY2022Q4 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
19073 | usd |
CY2021Q4 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
82 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
9495 | usd |
CY2021Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
8125 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
109946 | usd |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
74244 | usd |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
136847 | usd |
CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
153055 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
246793 | usd |
CY2021Q4 | us-gaap |
Assets
Assets
|
227299 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
1201937 | usd |
CY2021Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
1039661 | usd |
CY2022Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
1955820 | usd |
CY2021Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
1475067 | usd |
CY2021Q4 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
27299 | usd |
CY2022Q4 | us-gaap |
Loans Payable
LoansPayable
|
433600 | usd |
CY2021Q4 | us-gaap |
Loans Payable
LoansPayable
|
433600 | usd |
CY2022Q4 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
40000 | usd |
CY2021Q4 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
40000 | usd |
CY2022Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
13629 | usd |
CY2021Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
45664 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3644986 | usd |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3061293 | usd |
CY2022Q4 | SKVI |
Debt Instrument Related Party Unamortized Discount Premium Net
DebtInstrumentRelatedPartyUnamortizedDiscountPremiumNet
|
1228066 | usd |
CY2021Q4 | SKVI |
Debt Instrument Related Party Unamortized Discount Premium Net
DebtInstrumentRelatedPartyUnamortizedDiscountPremiumNet
|
1837918 | usd |
CY2022Q4 | us-gaap |
Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
|
2992143 | usd |
CY2021Q4 | us-gaap |
Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
|
2382291 | usd |
CY2022Q4 | us-gaap |
Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
|
101808 | usd |
CY2021Q4 | us-gaap |
Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
|
152642 | usd |
CY2022Q4 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
250267 | usd |
CY2021Q4 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
199433 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
6887396 | usd |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
5643017 | usd |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4539843 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4539843 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4539843 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4539843 | shares |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
4540 | usd |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
4540 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
30352905 | usd |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
30352905 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-36998048 | usd |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-35773161 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-6640603 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-5415716 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
246793 | usd |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
227299 | usd |
CY2022 | us-gaap |
Revenues
Revenues
|
279296 | usd |
CY2021 | us-gaap |
Revenues
Revenues
|
663426 | usd |
CY2022 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
4808 | usd |
CY2021 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
3300 | usd |
CY2022 | us-gaap |
Gross Profit
GrossProfit
|
274488 | usd |
CY2021 | us-gaap |
Gross Profit
GrossProfit
|
660126 | usd |
CY2022 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
18738 | usd |
CY2021 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
17939 | usd |
CY2022 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
494182 | usd |
CY2021 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
454107 | usd |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
512920 | usd |
CY2021 | us-gaap |
Operating Expenses
OperatingExpenses
|
472046 | usd |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-238432 | usd |
CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
188080 | usd |
CY2022 | us-gaap |
Interest Expense
InterestExpense
|
1162869 | usd |
CY2021 | us-gaap |
Interest Expense
InterestExpense
|
1213043 | usd |
CY2022 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
32035 | usd |
CY2021 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
-157478 | usd |
CY2022 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
144379 | usd |
CY2021 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
109688 | usd |
CY2022 | us-gaap |
Other Expenses
OtherExpenses
|
986455 | usd |
CY2021 | us-gaap |
Other Expenses
OtherExpenses
|
1260833 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1224887 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1072753 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-0.27 | |
CY2021 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-0.24 | |
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.27 | |
CY2021 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.24 | |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4539843 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4539843 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4539843 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4539843 | shares |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4454779 | usd |
CY2021 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
111816 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1072753 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-5415716 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1224887 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-6640603 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1224887 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1072753 | usd |
CY2022 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
18738 | usd |
CY2021 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
17939 | usd |
CY2022 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
660686 | usd |
CY2021 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
645686 | usd |
CY2022 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
144379 | usd |
CY2021 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
109688 | usd |
CY2022 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
32035 | usd |
CY2021 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
-157478 | usd |
CY2022 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-1370 | usd |
CY2021 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-1625 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-18991 | usd |
CY2021 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
7636 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
306655 | usd |
CY2021 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
174166 | usd |
CY2021 | us-gaap |
Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
|
-7616 | usd |
CY2022 | us-gaap |
Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
|
480753 | usd |
CY2021 | us-gaap |
Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
|
563382 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
45170 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
374605 | usd |
CY2022 | us-gaap |
Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
|
2530 | usd |
CY2021 | us-gaap |
Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
|
20864 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-2530 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-20864 | usd |
CY2022 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
27299 | usd |
CY2021 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
25200 | usd |
CY2021 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
180000 | usd |
CY2021 | us-gaap |
Payments For Loans
PaymentsForLoans
|
118400 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-27299 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-323600 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
15341 | usd |
CY2021 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
30141 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
66037 | usd |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
35896 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
81378 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
66037 | usd |
CY2021 | us-gaap |
Interest Paid
InterestPaid
|
12631 | usd |
CY2021 | SKVI |
Common Stock Payable Conversion Of Debt Value
CommonStockPayableConversionOfDebtValue
|
59602 | usd |
CY2022Q4 | us-gaap |
Intangible Assets Current
IntangibleAssetsCurrent
|
136847 | usd |
CY2022 | dei |
Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
|
1998-03-06 | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1224887 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-36998048 | usd | |
CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_84A_eus-gaap--UseOfEstimates_zpcWx8LDM8ni" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Use of estimates</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"/>The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company’s impairments and estimations of long-lived assets, allowances for uncollectible accounts, inventory valuation, and the valuations of non-cash capital stock issuances. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.1pt 0 0"> </p> | |
CY2022Q4 | us-gaap |
Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
|
4572284 | usd |
CY2022 | us-gaap |
Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
|
23609820 | shares |
CY2022 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
27299 | usd |
CY2021 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
25200 | usd |
CY2022Q4 | us-gaap |
Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
|
0 | usd |
CY2021Q4 | us-gaap |
Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
|
27299 | usd |
CY2019Q2 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
2464480 | usd |
us-gaap |
Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
|
966203 | usd | |
CY2019Q2 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
617915 | usd |
CY2019Q2 | us-gaap |
Accrued Vacation Current
AccruedVacationCurrent
|
64423 | usd |
CY2019Q2 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Reported Claims Amount
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount
|
11942 | usd |
CY2019Q2 | us-gaap |
Advance Royalties
AdvanceRoyalties
|
110245 | usd |
us-gaap |
Debt Instrument Description
DebtInstrumentDescription
|
The convertible promissory notes are unsecured, due five years from issuance, and bear an interest rate of 10%. At the investor’s option until the repayment date, the note may be converted to shares of the Company’s common stock at a fixed price of $0.20 per share along with warrants to purchase one share for every two shares issued at the exercise price of $0.30 per share for three years after the conversion date. | ||
CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Excluding Capital Leased Assets
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets
|
148273 | usd |
CY2021Q4 | us-gaap |
Intangible Assets Current
IntangibleAssetsCurrent
|
153591 | usd |
CY2021Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Excluding Capital Leased Assets
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets
|
129535 | usd |
CY2019Q4 | us-gaap |
Taxes And Licenses
TaxesAndLicenses
|
1000000 | usd |
CY2022 | SKVI |
Percent Payment Due To Avoid Termination
PercentPaymentDueToAvoidTermination
|
0.50 | pure |
CY2022 | SKVI |
License Fee Agreement Terms
LicenseFeeAgreementTerms
|
As partial consideration for the rights conveyed by Skinvisible under this Agreement, Licensee agrees to pay to Skinvisible a one-time, non-refundable, non-creditable license issue fee of one million USD dollars (USO $1,000,000) (''License Fee''). | |
SKVI |
License Revenues
LicenseRevenues
|
1000000 | usd | |
CY2022 | SKVI |
License Revenues2
LicenseRevenues2
|
250000 | usd |
CY2020Q2 | us-gaap |
Payments To Acquire Management Contract Rights
PaymentsToAcquireManagementContractRights
|
100000 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.21 | pure |
CY2022Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
37000000 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | pure |
CY2022Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
37000000.0 | usd |
CY2021Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
15700000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
7800000 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
3300000 | usd |
CY2022Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
7800000 | usd |
CY2021Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
3300000 | usd |
CY2022Q4 | us-gaap |
Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
|
37000000 | usd |
CY2021Q4 | us-gaap |
Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
|
15700000 | usd |
CY2022 | SKVI |
Schedule Of Option Summary
ScheduleOfOptionSummary
|
<table cellpadding="0" cellspacing="0" id="xdx_882_ecustom--ScheduleOfOptionSummary_zITZSFtYbGp3" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - 10. STOCK OPTIONS AND WARRANTS - Schedule of Option Summary (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Exercise Price</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify; padding-bottom: 1pt">Balance, December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231_zMXcsAjYV7vc">30,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--ExcercisePriceOneMember_zclxG24BTqv9">1.51</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Options granted and assumed</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20221231_zAJ5lpDUKtB5"><span style="-sec-ix-hidden: xdx2ixbrl0496">—</span></span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231_zcLsGYubAzI3"><span style="-sec-ix-hidden: xdx2ixbrl0497">—</span></span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Options expired</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20220101__20221231_zcHnC2D7iTi5">30,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__custom--OptionExerciseMember_zSi9NrRm8YU8"><span style="-sec-ix-hidden: xdx2ixbrl0499">—</span></span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Options canceled</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20221231_zzD3spWj1PD5"><span style="-sec-ix-hidden: xdx2ixbrl0500">—</span></span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--DerivativeInstrumentRiskAxis__custom--OptionCancelledWeightedAverageMember_zl0DnbuBHS04"><span style="-sec-ix-hidden: xdx2ixbrl0501">—</span></span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt">Options exercised</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220101__20221231_z9dNwsXSnCy4"><span style="-sec-ix-hidden: xdx2ixbrl0502">—</span></span> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231_zENToWc58ue1"><span style="-sec-ix-hidden: xdx2ixbrl0503">—</span></span> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt">Balance, December 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231_zms683xuYoa1"><span style="-sec-ix-hidden: xdx2ixbrl0504">—</span></span> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--ExcercisePriceTwoMember_zPQE9hejR7v8">1.51</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> </table> | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
30000 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
30000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4539843 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4539843 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4539843 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4539843 | shares |